Prot #PR-30-5011-C: A Phase 3 Randomized Double-Blind Trial of Maintenance with Niraparib Versus Placebo in Patients with Platinum Sensitive Ovarian Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date2/12/148/31/20

Funding

  • Parexel (Prot #PR-30-5011-C)
  • TESARO, Inc. (Prot #PR-30-5011-C)